MIRACLE Trial - Global Market Updates

AstraZeneca Fasenra approved in China for treating severe eosinophilic asthma, featuring an image of lungs and the medication.

Health

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

John - August 20, 2024 0

AstraZeneca's Fasenra (benralizumab) has been approved by China's National Medical Products Association (NMPA) for the treatment of severe eosinophilic asthma in patients aged 12...

Tata Motors Launches Curvv.ev, India’s First SUV Coupe, Starting at ₹17.49 Lakh

John - August 7, 2024

Muthoot Finance Named India’s Most Trusted Financial Services Brand for 8th Year

John - August 23, 2024

PM Modi Congratulates Wrestler Aman Sehrawat for Winning Bronze at Paris Olympics

John - August 10, 2024

India Expands FMD Vaccination to All Sheep and Goats Nationwide

John - August 18, 2024

Tag: MIRACLE Trial

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

EDITOR PICKS

Tata Motors Launches Curvv.ev, India’s First SUV Coupe, Starting at ₹17.49 Lakh

Muthoot Finance Named India’s Most Trusted Financial Services Brand for 8th Year

PM Modi Congratulates Wrestler Aman Sehrawat for Winning Bronze at Paris Olympics

India Expands FMD Vaccination to All Sheep and Goats Nationwide

EVEN MORE NEWS

Samsung Food+ Upgrades AI-Powered Features for Smarter, Healthier Cooking at IFA...

NVIDIA Launches AI-Driven NIM Agent Blueprint to Revolutionize Drug Discovery

Samsung Partners With Qualcomm to Enhance In-Vehicle Infotainment Systems

POPULAR CATEGORY